|
|
Treating Hyperkalemic Periodic Paralysis |
| 1F30AR081675-01 |
|
NIAMS |
2022 |
|
|
The Multiscale Role of Piezo Channels in Obesity-Associated Cartilage Damage |
| 1F31AR079260-01A1 |
|
NIAMS |
2022 |
|
|
Improving cell membrane repair to treat muscular dystrophy |
| 1F31AR080555-01 |
|
NIAMS |
2022 |
|
|
Local modulation of S1P receptor signaling with nanofibrous hyaluronic acid scaffolds as a regenerative immunotherapy following critical volumetric muscle loss injury |
| 1F31AR080563-01 |
|
NIAMS |
2022 |
|
|
Exploring the role of hypoxia signaling and its inhibition as a therapy for Facioscapulohumeral muscular dystrophy |
| 1F32AR079892-01A1 |
|
NIAMS |
2022 |
|
|
Identification and Imaging of Skeletal Muscle Response to Graded Nerve Crush |
| 1K08AR080260-01 |
|
NIAMS |
2022 |
|
|
The Role of Fat in Osteoarthritis |
| 1K99AR078949-01A1 |
|
NIAMS |
2022 |
|
|
Contribution of ribosome specialization to the pathophysiology of muscular dystrophy |
| 1K99AR081367-01 |
|
NIAMS |
2022 |
|
|
Phlpp phosphatases in osteoarthritis |
| 1R01AR078552-01A1 |
|
NIAMS |
2022 |
|
|
Therapeutic genetics and disease modeling in LAMA2-CMD |
| 1R01AR078872-01A1 |
|
NIAMS |
2022 |